CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 715 enrolled
Drug / intervention
Tele-CBTbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05635292
NCT05635292N/ACompleted

Addressing Disability Effectively With Psychosocial Telemedicine (ADEPT Study): An Open-label, Multicenter Pragmatic Randomized Control Trial

University of Pennsylvania·interventional·Posted Dec 2, 2022·Updated Oct 2, 2024

In Brief

A clinical study evaluating Tele-CBT for Crohn Disease. Completed, enrolled 715 participants across 1 site.

Detailed Summary

This multi-site study will be implemented at 5 gastroenterology practices to recruit 420 adults with IBD to complete a baseline survey and enroll those with higher scores on a validated IBD-disability scale into a randomized controlled trial of telehealth-delivered cognitive behavioral therapy with a licensed psychologist versus usual care. The investigators aim to lay the foundations that will shift the paradigm of IBD clinical practice towards a new horizon of holistic and equitable high-value care.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCrohn Disease
CountriesUnited States

Timeline

N/ACompletedFinished
2023202420252026
First PostedDec 2, 2022
Enrollment StartFeb 15, 2023
Primary CompletionJan 31, 2024
TodayJul 2, 2026
Enrollment to primary: 12 monthsPosted 3.6 years ago

Interventions

Tele-CBTbehavioral

8 weekly 1-hr telemedicine visits with a licensed Ph.D. psychologist from the University of Pennsylvania (permissible to practice across state lines under PSYPACT), plus usual care and referral to an IBD Help Center (email, phone, online chat with IBD information specialist)